Cargando…

Suprachoroidal hemorrhage associated with pars plana vitrectomy

PURPOSE: To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV). METHODS: Cases of SCH associated with PPV excluding trauma were retrospectively analyzed in Beijing Tongren Hospital between January 2010 and J...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Bin, Li, Song-Feng, Liu, Yi, Zhou, Jun, Wang, Shao-Li, Shi, Xiang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356403/
https://www.ncbi.nlm.nih.gov/pubmed/34380451
http://dx.doi.org/10.1186/s12886-021-02062-7
_version_ 1783736938683957248
author Mo, Bin
Li, Song-Feng
Liu, Yi
Zhou, Jun
Wang, Shao-Li
Shi, Xiang-Yu
author_facet Mo, Bin
Li, Song-Feng
Liu, Yi
Zhou, Jun
Wang, Shao-Li
Shi, Xiang-Yu
author_sort Mo, Bin
collection PubMed
description PURPOSE: To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV). METHODS: Cases of SCH associated with PPV excluding trauma were retrospectively analyzed in Beijing Tongren Hospital between January 2010 and June 2020. The data collected included general data, myopia status, axial length, state of the crystalline lens, SCH onset time, range, treatment method, visual prognosis, and methods of operation and anesthesia. Patients were divided into those with SCH related to the first PPV (Group 1), and SCH related to second intraocular surgery in the vitrectomized eye (Group 2). Patients were also classified by the SCH onset time into either the expulsive suprachoroidal hemorrhage group (ESCH) and the delayed suprachoroidal hemorrhage group (DSCH). The general data, related risk factors, and the visual prognosis of SCH in the different groups were analyzed. RESULTS: SCH associated with PPV was studied in 28 cases with an incidence of 0.06 %; 16 males and 12 females. The mean age of the patients was (53.51 ± 10.21) years old, the mean follow-up time was (24.94 ± 14.60) days, and the mean axial length was (28.21 ± 3.14) mm. Of these cases, 21 were classified as high myopia, 25 as aphakia/ pseudophakic, and 7 as focal hemorrhage. Silicone oil removal occurred in 12 cases (43 %). Patients in Group 2 were younger than Group 1 (P = 0.005). In terms of treatment and prognosis, 5 eyes were simply closely observed, 4 were given single suprachoroidal drainage, 15 were given suprachoroidal drainage combined with silicone tamponade, 2 underwent anterior chamber puncture, and 2 gave up treatment. A follow-up vision: NLP ~ 20/30; among them, 2 eyes with NLP (7.14 %), 6 of ≥ 20/200 (21.43 %). The final outcomes presented a significantly positive correlation with baseline vision but no significant correlation with age or axial length. CONCLUSIONS: SCH has a higher incidence rate after a second intraocular surgery in a vitrectomized eye which is associated with the lack of vitreous support and easier fluctuation of intraocular pressure. SCH associated with PPV is more localized and has a relatively good prognosis; high myopia and aphakic/ pseudophakic eyes are risk factors. Active treatment can effectively improve visual prognosis. TRIAL REGISTRATION: Retrospective case series study, not applicable.
format Online
Article
Text
id pubmed-8356403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83564032021-08-11 Suprachoroidal hemorrhage associated with pars plana vitrectomy Mo, Bin Li, Song-Feng Liu, Yi Zhou, Jun Wang, Shao-Li Shi, Xiang-Yu BMC Ophthalmol Research PURPOSE: To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV). METHODS: Cases of SCH associated with PPV excluding trauma were retrospectively analyzed in Beijing Tongren Hospital between January 2010 and June 2020. The data collected included general data, myopia status, axial length, state of the crystalline lens, SCH onset time, range, treatment method, visual prognosis, and methods of operation and anesthesia. Patients were divided into those with SCH related to the first PPV (Group 1), and SCH related to second intraocular surgery in the vitrectomized eye (Group 2). Patients were also classified by the SCH onset time into either the expulsive suprachoroidal hemorrhage group (ESCH) and the delayed suprachoroidal hemorrhage group (DSCH). The general data, related risk factors, and the visual prognosis of SCH in the different groups were analyzed. RESULTS: SCH associated with PPV was studied in 28 cases with an incidence of 0.06 %; 16 males and 12 females. The mean age of the patients was (53.51 ± 10.21) years old, the mean follow-up time was (24.94 ± 14.60) days, and the mean axial length was (28.21 ± 3.14) mm. Of these cases, 21 were classified as high myopia, 25 as aphakia/ pseudophakic, and 7 as focal hemorrhage. Silicone oil removal occurred in 12 cases (43 %). Patients in Group 2 were younger than Group 1 (P = 0.005). In terms of treatment and prognosis, 5 eyes were simply closely observed, 4 were given single suprachoroidal drainage, 15 were given suprachoroidal drainage combined with silicone tamponade, 2 underwent anterior chamber puncture, and 2 gave up treatment. A follow-up vision: NLP ~ 20/30; among them, 2 eyes with NLP (7.14 %), 6 of ≥ 20/200 (21.43 %). The final outcomes presented a significantly positive correlation with baseline vision but no significant correlation with age or axial length. CONCLUSIONS: SCH has a higher incidence rate after a second intraocular surgery in a vitrectomized eye which is associated with the lack of vitreous support and easier fluctuation of intraocular pressure. SCH associated with PPV is more localized and has a relatively good prognosis; high myopia and aphakic/ pseudophakic eyes are risk factors. Active treatment can effectively improve visual prognosis. TRIAL REGISTRATION: Retrospective case series study, not applicable. BioMed Central 2021-08-11 /pmc/articles/PMC8356403/ /pubmed/34380451 http://dx.doi.org/10.1186/s12886-021-02062-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mo, Bin
Li, Song-Feng
Liu, Yi
Zhou, Jun
Wang, Shao-Li
Shi, Xiang-Yu
Suprachoroidal hemorrhage associated with pars plana vitrectomy
title Suprachoroidal hemorrhage associated with pars plana vitrectomy
title_full Suprachoroidal hemorrhage associated with pars plana vitrectomy
title_fullStr Suprachoroidal hemorrhage associated with pars plana vitrectomy
title_full_unstemmed Suprachoroidal hemorrhage associated with pars plana vitrectomy
title_short Suprachoroidal hemorrhage associated with pars plana vitrectomy
title_sort suprachoroidal hemorrhage associated with pars plana vitrectomy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356403/
https://www.ncbi.nlm.nih.gov/pubmed/34380451
http://dx.doi.org/10.1186/s12886-021-02062-7
work_keys_str_mv AT mobin suprachoroidalhemorrhageassociatedwithparsplanavitrectomy
AT lisongfeng suprachoroidalhemorrhageassociatedwithparsplanavitrectomy
AT liuyi suprachoroidalhemorrhageassociatedwithparsplanavitrectomy
AT zhoujun suprachoroidalhemorrhageassociatedwithparsplanavitrectomy
AT wangshaoli suprachoroidalhemorrhageassociatedwithparsplanavitrectomy
AT shixiangyu suprachoroidalhemorrhageassociatedwithparsplanavitrectomy